Paul Andrew Moore

ZYME

Paul Andrew Moore serves as officer: Chief Scientific Officer at Zymeworks Inc. (ZYME). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$1.87M

Net Position

Net Seller

$1.87M

Companies Traded

ZYME

Active Period

Jan 2024 – Jan 2026

4 total trades

Most Recent

Sell ZYME

Jan 12, 2026 · $433.5K

Paul Andrew Moore's Insider Trading at Zymeworks Inc. (ZYME)

Buys

0 · $0.00

Sells

4 · $1.87M

Total Shares Bought

Total Shares Sold

90,339

ZYME Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 12, 2026	Sell	19,120	$22.67	$433.5K	48,497
Jan 5, 2026	Sell	40,220	$25.10	$1.01M	40,391
Jan 6, 2025	Sell	21,200	$14.92	$316.4K	23,333
Jan 8, 2024	Sell	9,799	$10.79	$105.7K	9,706

Related Insiders

Mark Hollywood

officer: EVP & Chief Operating Officer

ZYMESell · Jan 13, 2026

Kenneth Galbraith

director, officer: Chair & CEO

ZYMESell · Jan 12, 2026

Jeffrey T L Smith

officer: EVP & Chief Medical Officer

ZYMESell · Jan 12, 2026

Explore More Insider Trading Data

ZYME Insider Trading Activity

View all insider trades at Zymeworks Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity